Cargando…
Immune Effects of Corticosteroids in Sepsis
Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077259/ https://www.ncbi.nlm.nih.gov/pubmed/30105022 http://dx.doi.org/10.3389/fimmu.2018.01736 |
_version_ | 1783344873287450624 |
---|---|
author | Heming, Nicholas Sivanandamoorthy, Sivanthiny Meng, Paris Bounab, Rania Annane, Djillali |
author_facet | Heming, Nicholas Sivanandamoorthy, Sivanthiny Meng, Paris Bounab, Rania Annane, Djillali |
author_sort | Heming, Nicholas |
collection | PubMed |
description | Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies on source control and organ support. Septic shock, the most severe form of sepsis is associated with the highest rate of mortality. Two large multicentre trials, undertaken 15 years apart, found that the combination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock. The corticosteroids family is composed of several molecules that are usually characterized according to their glucocorticoid and mineralocorticoid power, relative to hydrocortisone. While the immune effects of glucocorticoids whether mediated or not by the intracellular glucocorticoid receptor have been investigated for several decades, it is only very recently that potential immune effects of mineralocorticoids via non-renal mineralocorticoid receptors have gained popularity. We reviewed the respective role of glucocorticoids and mineralocorticoids in counteracting sepsis-associated dysregulated immune systems. |
format | Online Article Text |
id | pubmed-6077259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60772592018-08-13 Immune Effects of Corticosteroids in Sepsis Heming, Nicholas Sivanandamoorthy, Sivanthiny Meng, Paris Bounab, Rania Annane, Djillali Front Immunol Immunology Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies on source control and organ support. Septic shock, the most severe form of sepsis is associated with the highest rate of mortality. Two large multicentre trials, undertaken 15 years apart, found that the combination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock. The corticosteroids family is composed of several molecules that are usually characterized according to their glucocorticoid and mineralocorticoid power, relative to hydrocortisone. While the immune effects of glucocorticoids whether mediated or not by the intracellular glucocorticoid receptor have been investigated for several decades, it is only very recently that potential immune effects of mineralocorticoids via non-renal mineralocorticoid receptors have gained popularity. We reviewed the respective role of glucocorticoids and mineralocorticoids in counteracting sepsis-associated dysregulated immune systems. Frontiers Media S.A. 2018-07-30 /pmc/articles/PMC6077259/ /pubmed/30105022 http://dx.doi.org/10.3389/fimmu.2018.01736 Text en Copyright © 2018 Heming, Sivanandamoorthy, Meng, Bounab and Annane. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Heming, Nicholas Sivanandamoorthy, Sivanthiny Meng, Paris Bounab, Rania Annane, Djillali Immune Effects of Corticosteroids in Sepsis |
title | Immune Effects of Corticosteroids in Sepsis |
title_full | Immune Effects of Corticosteroids in Sepsis |
title_fullStr | Immune Effects of Corticosteroids in Sepsis |
title_full_unstemmed | Immune Effects of Corticosteroids in Sepsis |
title_short | Immune Effects of Corticosteroids in Sepsis |
title_sort | immune effects of corticosteroids in sepsis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077259/ https://www.ncbi.nlm.nih.gov/pubmed/30105022 http://dx.doi.org/10.3389/fimmu.2018.01736 |
work_keys_str_mv | AT hemingnicholas immuneeffectsofcorticosteroidsinsepsis AT sivanandamoorthysivanthiny immuneeffectsofcorticosteroidsinsepsis AT mengparis immuneeffectsofcorticosteroidsinsepsis AT bounabrania immuneeffectsofcorticosteroidsinsepsis AT annanedjillali immuneeffectsofcorticosteroidsinsepsis |